A Translational Study for Prediction of Biomarkers and Identification of Phenotype and Endotype of COPD and Early COPD Outcomes in Chinese Population

Study identifier:D2287R00187

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Will Be Recruiting

Official Title

A Translational Study in Patients with COPD and Early COPD to Describe Patient Clinical Characteristics, Treatment Patterns, Biomarkers and to Identify Phenotypes and Endotypes associated with Differential Outcomes that may Support Future Development of Personalized Treatment Strategies in Chinese Population

Medical condition

COPD

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Estimated Enrollment

850

Study type

Observational

Age

30 Years - n/a

Date

Study Start Date: 30 May 2024
Estimated Primary Completion Date: 01 Jul 2027
Estimated Study Completion Date: 01 Jul 2027

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 May 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria